Pune Media

Japanese biopharma firm Takeda to hire 750 techies in India

Takeda, a Japanese biopharmaceutical firm, on Wednesday said it would hire 750 deeptech professionals in calendar 2025 to be deployed at its newly set-up Innovation Capability Centre (ICC) in Bengaluru.

The company had already hired 270 software developers, scrum masters, AI specialists and data analysts, said a spokesperson.

Takeda, which operates as Takeda Pharmaceuticals India in the country, mainly focuses on oncology, gastroenterology, rare diseases, neuroscience, plasma-derived therapies and vaccines.

Takeda’s ICC in Bengaluru would work in collaboration with its similar centres in Slovakia and Mexico which cumulatively employs around 700 deep-tech talent.

The launch of Bengaluru ICC was a pivotal moment for Takeda’s digital transformation journey globally, said Gabriele Ricci, Chief Data and Technology Officer, Takeda, in a media conference.

‘’It represents Takeda’s strategic commitment to apply data and new digital technologies such as artificial intelligence, digital twin and block etc to drive innovation in global healthcare research and development,’‘ he said.

According to Mr. Ricci, the ICC in India will develop key technology capabilities by embracing data and digital solutions using an agile, patient-centric and solution focused approach. The centre would focus on pioneering advancements across domains including AI and GenAI to enhance efficiency and predictive analytics in healthcare in addition device engineering, application virtualisation, data science and visualisation to enable data-driven decisions for improved patient outcomes, he added.

Published – January 15, 2025 08:42 pm IST



Images are for reference only.Images and contents gathered automatic from google or 3rd party sources.All rights on the images and contents are with their legal original owners.

Aggregated From –

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More